IP

Employee’s Rights to Compensation for Inventions – a European Perspective

By Inside EU Life Sciences on March 5, 2010

Posted in Employment, Intellectual Property

Article originally published in PLC Life Sciences Handbook 2009/2010

Many life science companies rely on their employees’ inventiveness to fuel their research and development (R&D) efforts and generate patents. The most successful inventions can generate billions of euros of sales annually. In some circumstances, the employees who created the patentable…
Continue Reading Employee’s Rights to Compensation for Inventions – a European Perspective

DG Competition’s Preliminary Report on the Pharma Sector Inquiry: A Need for Clear Signals at the IP/Competition Intersection

By Inside EU Life Sciences on February 15, 2009

Posted in Competition, Intellectual Property

Article originally published in Global Competition Policy, February 2009

The release of DG Competition’s Preliminary Report on its Pharmaceutical Sector Inquiry on November 28, 2008 was a Brussels media event, with press briefings, press releases, and an all-day public hearing that was covered by the Commission’s live television channel.¹…

Continue Reading DG Competition’s Preliminary Report on the Pharma Sector Inquiry: A Need for Clear Signals at the IP/Competition Intersection

Medical Nanotechnology in Europe

By Peter Bogaert & Brian Kelly on July 1, 2008

Posted in Food & Drug Regulatory, Medical Devices, Medicinal Products

Article originally published in RAJ Pharma in July 2008

By 2015 nanotechnology-based medicines and medical devices are expected to flood the global market. Brian Kelly and Peter Bogaert discuss the regulatory and legal implications of medical nanotechnology in Europe.

Nanotechnologies are the design, characterisation, production and application of structures, devices…
Continue Reading Medical Nanotechnology in Europe